期刊文献+

40名健康青年女性乳腺组织不同回波时间的~1H-MRS分析 被引量:1

Proton ~1H MR Spectroscopy of Breast Tissues with Different Echo Time
原文传递
导出
摘要 目的探讨MR在不同回波时间(echo times,TE)对正常乳腺组织胆碱复合物(Cho)氢质子磁共振波谱(1H-MRS)的影响,为研究正常乳腺及乳腺疾病的诊断和鉴别诊断提供客观依据。资料与方法选择40名健康未婚青年女性自愿者,平均年龄(21.4±2.4)岁(20~24岁),所有自愿者均行常规MRI,在其基础上选择感兴趣区(ROI)并行二维1H-MRS检查,TR为1500ms,TE分别为80ms、110ms、135ms、270ms,分析不同TE下健康青年女性的正常乳腺组织的1H-MRS图形,并对比不同TE是否出现Cho峰和对Cho峰阳性率的影响。结果 TE为80ms时,探测到可辨认的Cho峰阳性率为15.0%(6/40);TE为110ms,阳性率17.5%(7/40);TE为135ms时,阳性率20%(8/40);TE为270ms时,阳性率17.5%(7/40),各阳性率之间差异无统计学意义(P(0.05);在乳腺的1H-MRS检查中,TE在110~270ms之间为探测Cho峰的最佳TE。结论 Cho峰在健康青年女性少部分乳腺组织中可探及,但仅表现为低振幅;随着TE的延长,探测到Cho峰的可能性越大,其临床应用价值有待进一步研究。 Objective To explore the choline contents in the normal breasts of healthy young woman with different echo times(TE),in order to offer the objective evidence for the diagnosis and differential diagnosis of normal breasts or breast lesions.Materials and Methods Forty unmarried young women were selected as health volunteers with the average age of 21.4±2.4(20-24 years old).All volunteers underwent conventional MRI scan and 2D 1H magnetic resonance spectroscopy(MRS)with different TE(80,110,135,and 270 ms).The choline contents were calculated under different TE.Results Under TE=80 ms,the detection rate of choline identifiable peak was 15.0%(6/40);TE=110 ms,the detection rate was 17.5%(7/40);TE=135 ms,the detection rate was 15.0%(8/40);TE=270 ms,the detection rate was 17.5%(7/40).The optimization TE was 110-270 ms for detecting choline peak.Conclusion The Cho peak with low amplitude can be detected in some normal breast tissue.With increasing the echo time,the detection rate of identifiable choline peak increased.The clinical value of spectroscopy need to be studied further.
出处 《临床放射学杂志》 CSCD 北大核心 2010年第12期1621-1624,共4页 Journal of Clinical Radiology
基金 乌鲁木齐市科学计划项目(编号:30260108)
关键词 磁共振波谱 回波时间 正常乳腺组织 Magnetic resonance spectroscopy Echo time Normal breast tissue
  • 相关文献

参考文献21

  • 1Castillo M, Kwock L, Mukherji SK, et al. Clinical applications of proton MR spectroscopy. AJNR, 1996,7 : 1.
  • 2Bartella L, Morris EA, Dershaw DD, et al, Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology, 2006,239:686.
  • 3Yeung DK, Cheung HS,Tse GM. Human breast lesions:characterization with contrast enhanced in vivo proton MR spectroscopy-initial results. Radiology, 2001,220:40.
  • 4Mackinnon WB, Barry PA, Malycha PL, et al, Fine-needle biopsyspecimens of benign breast lesions distinguished from invasive cancerex vivo with proton MR spectroscopy. Radiology, 1997,204 : 661.
  • 5Tse GM, Cheang HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy:comparison of carcino2mas,benign lesions,and phyllodes tumors. AJR ,2003,181:1267.
  • 6Zhao B ,Cai SF ,Yu TF ,et al. Study of clinical value and influen-cing faetor of ^1H-MR spectroscopy in mammary tumours. Chin J Radiol, 2006,40 : 281.
  • 7Jacobs MA, Barker PB, Arganl P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging,2005,21:23.
  • 8Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal Human breast tissues with in vivo ^1H-MR spectroscopy. J Magn Reson hnaging, 1999,10:159.
  • 9Cecil KM, Schnall MD, Siegchnan ES, et al. The evaluation of Human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat,2001,68:45.
  • 10Jagannathan NR,Seenu V, Kumar M. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent. Radiology ,2002,223:281.

二级参考文献38

  • 1赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 2Roebuck JR, Cecil KM, Schnall MD, et al. Human breast lesions: characterization with proton MR spectroscopy[J]. Radiology,1998, 209(1): 269-275.
  • 3Huang W, Fisher PR, Dulaimy K, et al. Detection of breast malignancy: diagnostic MR protocol for improved specificity [J]. Radiology, 2004, 232(2): 585-591.
  • 4Yeung DKW, Cheung HS, Tse GMK. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroseopy-initial results[J]. Radiology, 2001. 220(1): 40-46.
  • 5Stanwell P, Gluch L, Clark D, et al. Specificity of Choline metabolites for in vivo diagnosis of breast cancer using ^1H MRS at 1.5T[J]. Eur Radiol, 2005. 15(5): 1037-1043.
  • 6Jacobs MA. Barker PB, Argani P. et al. Combined Dynamic Contrast Enhanced Breast MR and Proton Spectroscopic Imaging: A Feasibility Study[J]. J Magn Reson Imag, 2005. 21(1): 23-28.
  • 7Kvistad KA, Bakken U, Gribbestad IS. et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy [J]. J Magn Reson Imaging, 1999, 10 (2): 159- 164.
  • 8北京化学试剂公司.化学试剂目录分册[M].北京:北京工业大学出版社,1993.171.
  • 9Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with ^1H MR spectroscopy[J]. Magn Reson Med, 2003, 50(6): 1134-1143.
  • 10Bakken IJ, Gribbestad IS. Singstad TE, et al. External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5Tesla [J]. Magn Reson Med, 2001. 46(1): 189-192.

共引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部